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Abstract: Background: Post-stroke dysphagia leads to increased risk of aspiration and subsequent
higher risk of pneumonia. It is important to not only diagnose post-stroke dysphagia early but also
to evaluate the protective mechanism that counteracts aspiration, i.e., primarily cough. The aim of
this study was to investigate the predictive value of cough frequency in addition to aspiration risk
for pneumonia outcome. Methods: This was a single-center prospective observational study. Patients
with first-ever strokes underwent clinical swallowing evaluation, fibreoptic endoscopic evaluation of
swallowing (FEES), and overnight cough recording using LEOSound® (Löwenstein Medical GmbH
& Co. KG, Bad Ems, Germany ). Penetration–Aspiration Scale (PAS) ratings and cough frequency
measurements were correlated with incidence of pneumonia at discharge. Results: 11 women (37%)
and 19 men (63%), mean age 70.3 years (SD ± 10.6), with ischemic stroke and dysphagia were
enrolled. Correlation analysis showed statistically significant relationships between pneumonia and
PAS (r = 0.521; p < 0.05), hourly cough frequency (r = 0,441; p < 0.05), and categories of cough severity
(r = 0.428 p < 0.05), respectively. Logistic regression showed significant predictive effects of PAS
(b = 0.687; p = 0.014) and cough frequency (b = 0.239; p = 0.041) for pneumonia outcome. Conclusion:
Cough frequency in addition to aspiration risk was an independent predictor of pneumonia in
dysphagic stroke survivors.
Keywords: cough frequency; dysphagia; aspiration; post-stroke pneumonia; diagnostics; FEES
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1. Introduction
Stroke is the second leading cause of death worldwide and is associated with many
complications, such as long hospital stays and significant health care costs [1]. One common
consequence of stroke is dysphagia [2], which leads to an increase in aspiration episodes,
subsequent high risk of post-stroke pneumonia, and increased mortality [3,4].
International guidelines recommend overarching aspects of the diagnosis of dyspha-
gia, including early swallow screening, clinical assessment, and—if available—formal
instrumental diagnostics, such as a videofluoroscopic swallow study (VFSS) or fibreoptic
endoscopic evaluation of swallowing (FEES) [5–7]. Non-instrumental assessments are an
important base for making a preliminary diagnosis and defining the dysphagia manage-
ment plan [8]. However, to address aspiration and other physiological problems in the
pharyngeal phase of swallowing, a direct observation with instrumental assessment is
required [9–11]. The implementation of instrumental diagnostics is therefore seen as an
important and valuable addition to dysphagia diagnostics [11–13]. FEES investigation pro-
vides direct information about oropharyngeal secretion management and the effectiveness
of clearing mechanisms, such as throat clearing and coughing [14].
Regarding the detection of critical events such as penetrations and aspirations, FEES
is at least as efficient as VFSS [15,16]. The occurrence of two or more of the following
symptoms may indicate aspiration: dysphonia, dysarthria, lack of gag reflex, inadequate
coughing, altered voice quality, and coughing after swallowing [17]. Aspirations can also be
asymptomatic, e.g., not accompanied by reflexive protective cough. These so-called silent
aspirations increase the risk of pneumonia by a factor of 1.3 compared to aspirations that
are accompanied by clinical symptoms [18]. The relationship between coughing disorder,
aspiration, and pneumonia has been described in the literature [19]. It is of great relevance
to not only diagnose swallowing disorders at an early stage, but to also precisely diagnose
the protective mechanism (i.e., cough) that counteracts the risk of aspiration.
In principle, three main aspects of cough are of interest in clinical settings: reflex
cough sensitivity, volitional cough strength, and frequency of spontaneous cough [20]. The
frequency of coughing is measured primarily in research on respiratory diseases, which
cause refractory cough [21] and can inform about the severity of a refractory cough as well
as about the etiology of the disease [22]. In connection with dysphagia, most cough research
has focused on assessing reflex cough sensitivity or volitional cough strength, but there
has been very little research on the role of cough frequency in the context of post-stroke
dysphagia [23]. Only very few studies have explored cough frequency in neurological
patient groups [24,25]. The incidence of coughs can be measured either by patient self-
report, counting of cough episodes by an observer, or by portable cough monitors that are
commercially available. One example of such a cough monitor device is the LEOSound
system [26]. LEOSound® is a validated, fully automated lung sound monitor, which
works as ”long-term stethoscope” and enables continuous objective respiratory sound
auscultation for up to 24 h. The device detects, measures, and counts cough events with
a sensitivity of 93% and a specificity of 99% [22,26]. The results of long-term cough
recordings could potentially provide important information to enhance the results of the
dysphagia diagnosis.
The aim of this study was to evaluate the predictive value of cough frequency in
addition to aspiration risk for increased risk of post-stroke pneumonia.
2. Materials and Methods
This was a prospective observational cohort study. All patients or their legal guardians
were informed about the study and gave their written consent. For those patients who
were unable to provide their own research consent, the relatives and or legal guardians
were approached and they consented on the patients’ behalf.
The local ethics committee approved the study protocol (Kantonale Ethikkommision
Zürich, BASEC-No. 2019-01592).
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2.1. Participants
All patients were referred for neurological rehabilitation from stroke units and acute
wards of various regional hospitals to the Zurcher RehaZentren, Klinik Wald, Switzerland,
between February and October 2020 following acute onset of stroke.
The inclusion criteria were:
(1) Age between 18–85 years;
(2) First ever stroke (ICD-10-CM Code: Cerebrovascular diseases, I60-I69);
(3) Clinical suspicion of neurogenic swallowing disorder up to 6 weeks post-onset.
Exclusion criteria were:
(1) The presence of neurological condition other than stroke, which could lead to dysphagia;
(2) Known history of swallowing difficulties due to previous stroke;
(3) Any other diseases correlating with increased risk of coughing during night-time
measurement (i.e., COPD, asthma);
(4) Pneumonia;
(5) Acute infection;
(6) Requirement for invasive or non-invasive ventilation;
(7) Physical or cognitive impairments leading to limitation in the performance of planed
diagnostics (i.e., agitation);
(8) Discharged before assessments could be completed.
2.2. Procedures
Within seven days of admission to the Zürcher Reha Zentren, patients underwent
complete dysphagia diagnostic procedures. Immediately after enrolment, the patient
baseline data was collected from the clinical information system (PhoenixTM, CompuGroup
Medical AG, Bern, Switzerland).
2.2.1. Functional Independence Measurement (FIM)
The Functional Independence Measure (FIM) was administered to document the
severity of physical and psychological disability of our patients at admission and before
discharge [27]. FIM is an 18-item tool that quantifies the changes in functional limitations
of patients during rehabilitation.
2.2.2. Dysphagia Screening and Clinical Swallowing Evaluation
Risk of dysphagia was first assessed with the Standardized Swallowing Assessment
(SSA) using a binary present/absent scoring [28].
Following the results of the SSA, a clinical swallowing evaluation (CSE) combined
with the 3 ounce water swallow test [29] was performed according to the in-house protocol
based on the screening protocol for neurogenic dysphagia [30].
During both examinations we investigated items relevant for swallowing, such as level
of alertness and ability to manage saliva, as well as water swallowing and standardized
test meal swallowing (applesauce, banana, and bread).
The aspiration predictors, following Daniels [17], were recorded during the examina-
tion using a binary present/absent scoring. The patient was considered at risk of aspiration
if two or more of the following aspiration predictors were scored as present: (1) cough after
swallow, (2) voice change after swallow, (3) abnormal volitional cough, (4) abnormal gag
reflex, (5) dysarthria, (6) dysphonia.
2.2.3. Instrumental Diagnostics of Dysphagia
We performed instrumental diagnostics of dysphagia using FEES (rpSzene®, Rehder
& Partner Company, Methfesselstrasse, Hamburg, Germany) according to the recommen-
dations by Langmore [31].
An experienced neurologist or a certified speech-language-pathologist carried out the
FEES. It was recorded and video-analyzed by the assessor team.
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Our in-house protocol includes examination of the condition, function and sensi-
tivity of the anatomical structures included in swallowing, rating of secretion manage-
ment, and direct swallowing examination. Defined amounts of pudding-like consistency
(1 teaspoon = 5 mL), water (1 teaspoon = 5 mL, 1 sip = 10 mL), and solid food (biscuit,
5 g) were offered three times in succession. If any of the consistencies were considered
unsafe, we no longer tested the corresponding consistency. All grading procedures dur-
ing the FEES examination, described below, were carried out according to international
standards [32–34].
Penetration–Aspiration-Scale (PAS)
We graded the severity of penetration or aspiration according to Rosenbek’s Penetration–
Aspiration Scale (PAS) [32], with the highest PAS score of all tested consistencies recorded.
We classified the results as follows:
(1) PAS I–II: Normal–mild (no aspiration, penetration with clearing);
(2) PAS III–V: Moderate (penetrations);
(3) PAS VI–VIII: Severe (aspirations), with PAS VIII defined as silent aspiration.
Rating of Secretion (ROS)
We graded the accumulation of secretion according to the Murray Rating of Secretion
Scale (ROS) [33], where the results were classified as follow:
(1) ROS 0: Normal rating;
(2) ROS 1: Any secretions evident upon entry in the protective structures surrounding
the laryngeal vestibule that were bilaterally represented or deeply pooled;
(3) ROS 2: Any secretions that changed from a “1” rating to a “3” rating during the
observation period;
(4) ROS 3: Any secretions seen in the area defined as the laryngeal vestibule, where pul-
monary secretions were included if they were not cleared by swallowing or coughing
by the close of the segment.
Airway Protection
We graded the airway protection for patterns of tight breath holding (PTBH) following
Murray [34] and classified it as follow:
(1) PTBH 1: Breath holding not achieved;
(2) PTBH 2: Transient breath holding with glottis open;
(3) PTBH 3: Sustained breath holding with glottis open;
(4) PTBH 4: Transient true vocal fold closure;
(5) PTBH 5: Sustained true vocal fold closure;
(6) PTBH 6: Transient true and ventricular fold closure;
(7) PTBH 7: Sustained true and ventricular fold closure.
2.2.4. Cough Monitor Assessment
Following FEES, patients underwent an 8 h nocturnal cough frequency recording
with the LEOSound® system. Respiratory sounds were recorded continuously by three
small bio-acoustical sensors (microphones) placed on the patient’s back and at the anterior
neck of the patient (Figure 1). The placement of the two microphones on the back was
chosen after auscultation. Recordings started between 9 p.m. and 10 p.m. After the
recordings were completed, recordings were transferred to a computer and analyzed
with LEOSound-Analyser® (Löwenstein Medical GmbH & Co. KG, Bad Ems, Germany)
software. LEOSound-Analyser® automatically evaluates the data for the presence of
respiratory sounds such as wheezing and coughs along with the respiratory rate and
stores the results and the raw data in a database. The chief physician (pulmonologist)
manually double-checked the accuracy of cough episodes as reported by LEOSound® on
the recordings as indicated by LEOSound® and listening to the recording at that time
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stamp. The chief physician then judged whether the cough sound was actually a cough
sound. This was done in approximately 1/5 of patients’ recordings and all sounds matched
the characteristics of true cough sounds.
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Figure 1. Setup of trachea and lung bio-acoustical microphones for the LEOSound® cough recording.
Hourly Cough Rate (HCR)
Hourly cough rate (HCR) was presented in a numerical form.
Categorized Hourly Cough Events (CHCE)
Categorized hourly cough events (CHCE) were classified as follow:
(1) None: 0 average HCRs;
(2) Minor: 1–2 average HCRs;
(3) Moderate: 3–5 average HCRs;
(4) Distinct: 6 or more average HCRs.
2.2.5. Follow-Up for Incidence of Pneumonia
The occurrence of pneumonia during the neurological inpatient rehabilitation stay
was documented from the patient’s medical record on the day of discharge. A diagnosis of
pneumonia was determined according to guidelines [35] when all the following occurred:





All statistical analyses were performed using STATISTICA (Stat Soft, Inc., Tulsa, OK,
USA, 2018, version 12). Descriptive statistics were expressed as means ± SD, frequencies,
and percentages. The Shapiro–Wilk, Levene, and Mauchly’s tests were used to verify
the normality, homogeneity, and sphericity of the sample’s data variances, respectively.
Correlation analysis with Pearson’s coefficient was used to determine the strength of the
relationship between pneumonia and the variables PAS, ROS, PTBH, HCR, and CHCE. For
the variable CHCE, values 1–4 were entered for the respective CHCE categories. Stepwise
multiple regression was used to select explanatory variables offering the best predictors for
pneumonia in the model construction phase. Ultimately, three predictor variables were
used to form a regression model predicting the occurrence of pneumonia. The level of
significance for all analyses was set at p ≤ 0.05.
3. Results
Between February and October 2020, 234 patients with a diagnosis of stroke were
admitted for neurological rehabilitation to the Zurcher RehaZentren, Klinik Wald, Switzer-
land, after hospitalization following acute onset of stroke. Thirty patients met the study
inclusion criteria and were enrolled. The flow of participants through the study is shown
in Figure 2.
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Figure 2. flow.
Patients presented to our rehabilitation facility within one month after stroke onset.
The study sample consisted of 11 women (37%) and 19 men (63%) with a mean age of
70.3 years (SD ± 10.6; range 47–85). Demographic and clinical patient characteristics, as
well as timings of assessments, are summarized in Table 1.
Table 2 presents descriptive statistics of all variables analyzed in this study.
Table 3 shows the results of the correlation analysis for the dependent
variable pneumonia.
Correlation analysis showed statistically significant associations between pneumonia
and PAS (r = 0.521; p < 0.05), HCR (r = 0.441; p < 0.05), and CHCE (r = 0.428; p < 0.05), with
slightly higher correlation coefficients for PAS than for CHCE and HCR.
In the next step, a stepwise regression analysis was performed to determine the most
important predictors for pneumonia. Results are shown in Tables 4 and 5.
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Table 1. Participant characteristics.




Age, years (mean, SD) 70.3 (10.6)
Height, cm (mean, SD) 170.4 (10.6)
Weight, kg (mean, SD) 70.8 (13.2)
BMI (mean, SD) 24.3 (3.7)
Stroke etiology (n, %)
Ischemic 26 (86.7)
Hemorrhagic 4 (13.3)






Total score 64.7 (23.7)
Cognitive sub-score 22.8 (10.9)
Motor sub-score 41.9 (17.6)
Aphasia (n, %) 12 (40.0)
ACE inhibitors (n, %) 3 (10.0)
Nasogastric tube (n, %) 5 (16.7)
PEG/PEJ tube (n, %) 7 (23.3)
Length of stay, days (median, range) 38 (5, 86)
Pneumonia incidence during rehabilitation stay (n, %) 10 (33.3)
Admission to SSA, days (median, range) 0 (0, 1)
SSA to CSE, days (median, range) 0 (0, 3)
CSE to FEES, days (median, range) 2 (0, 5)
FEES to overnight cough monitor (LEOSound),
days (median, range) 0 (0, 2)
BMI, body mass index; FIM, Functional Independence Measure; ACE, angiotensin-converting enzyme; PEG,
percutaneous endoscopic gastrostomy; PEJ, percutaneous endoscopic jejunostomy; SSA, Standardized Swallowing
Assessment; CSE, clinical swallowing evaluation; FEES, fibreoptic endoscopic evaluation of swallowing.
The ROS, PTBH, and CHCE variables were outside the model. The analysis showed
that ROS, PTBH, and CHCE had no predictive effect for pneumonia.
The regression model was expressed by the following equation:
Y − (Pneumonia = 1) = −4.916 + 0.687 × PAS + 0.239 × HCR
This equation expresses that an increase in PAS by one unit resulted in an increase
in pneumonia by 0.687; and a simultaneous increase in HCR by one unit resulted in an
increase in pneumonia by 0.239. The stepwise logistic regression analysis showed that the
beta value of PAS (0.687) had a greater impact on pneumonia than the HCR variable (0.239).
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Table 2. Results for descriptive statistics for PAS, ROS, PTBH, HCR, CHCE, and pneumonia.
Variables Sample (n = 30)
PAS (n)—(mean, SD) 6 (2.300)
ROS (n)—(mean, SD) 0 (0.681)
PTBH (n)—(mean, SD) 5 (1.545)
HCR (n)—(mean, SD) 4 (7.718)
CHCE (des)—(mean, SD) 2 (2.355)
Pneumonia (bi)—(mean, SD) 0 (0.479)
PAS, Penetration–Aspiration Scale; ROS, rating of secretion; PTBH, patterns of tight breath holding; HCR, hourly
cough rate; CHCE, categorized hourly cough event; bi, binary; des, descriptive; n, numeral.







PAS, Penetration Aspiration Scale; ROS, rating of secretion; PTBH, patterns of tight breath holding; HCR, hourly
cough rate; CHCE, categorized hourly cough events; statistically significant value in bold.
Table 4. Results of stepwise regression analysis for dependent variable pneumonia—variables in
the model.
Variables in Model Beta OR p * −95% CL 95% CL
Constant −4.916 0.007 0.011 0.000 0.332
PAS 0.687 1.987 0.014 1.146 3.445
HCR 0.239 1.270 0.041 1.011 1.595
PAS, Penetration Aspiration Scale; HCR, hourly cough rate; * statistically significant value in bold.
Table 5. Results of stepwise regression analysis for dependent variable pneumonia—variables
outside the model.
Variables Outside Model Beta OR p −95% CL 95% CL
ROS 0.052 0.487 0.303 0.118 2.843
PTBH 0.082 0.157 0.411 0.776 2.631
CHCE 0.105 0.740 0.102 0.457 1.133
ROS, rating of secretion; PTBH, patterns of tight breath holding; CHCE, categorized hourly cough event.
4. Discussion
The aim of this study was to evaluate the predictive value of cough frequency in
addition to aspiration risk for outcome pneumonia.
In this prospective cohort of 30 consecutive patients with first-ever acute strokes, we
were able to demonstrate statistically significant associations (p < 0.05) between pneumonia
outcome and PAS ratings according to instrumental swallowing diagnostics using FEES
and HCR determined by cough monitor measurement, respectively.
Two possible, somewhat opposing, mechanisms could explain why cough frequency
constitutes a predictor for pneumonia in dysphagic stroke patients. On the one hand,
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abnormally low cough frequency could indicate impaired reflex cough sensitivity and
reduced protection of the lower respiratory tract, predisposing patients to higher risk of
pneumonia through silent aspiration. On the other hand, abnormally increased cough
frequency could indicate frequent protective coughs triggered in response to frequent
(micro-)aspiration events. In our data, there was a wide range of hourly cough rates
among study participants with poor swallowing function, from normal/unremarkable to
abnormally high. For example, in the categorization of hourly cough rates (none, minor,
moderate, and distinct) among the 15 participants with PAS ratings of 7–8, eight had
moderate or distinct hourly cough events, while seven had minor events or none. Our
analysis supports the second of the above-mentioned possible mechanisms, i.e., increased
cough frequency as an indicator and ”warning sign” of aspiration and increased risk
of pneumonia.
The literature offers very limited data on the role of cough frequency in the context
of impaired swallowing and pneumonia risk in stroke and other neurological patient
groups. Hadjikoutis et al., 2000, presented data on self-reported occurrence of coughing
and choking episodes in patients with motor neuron disease [24]. In their population,
coughing and choking episodes were common but infrequently associated with overt
chest infection. Kulnik et al., 2015, in their longitudinal one-month observational study,
noted that average nocturnal cough frequency as measured with the Leicester Cough
Monitor [36] in acute-stroke survivors was higher at baseline and reduced over time,
with wide individual variability [25]. Their results support our suggestion that frequent
protective coughs triggered in response to frequent aspiration events may constitute the
underlying mechanism by which higher cough frequency indicates increased pneumonia
risk. This also aligns with the general tendency of spontaneous recovery of dysphagia
following acute stroke; if frequent coughing occurs as a response to (micro-)aspiration
events, abnormally high cough frequency would resolve as dysphagia improves over time.
Three of our patients with abnormally high hourly cough rates (39, 15, and 6 each) were
using ACE inhibitors, which are known to induce cough in a proportion of patients [37].
For medical reasons, ACE inhibitors could not be discontinued to monitor cough in this
study. The cough-inducing effect of ACE inhibitors affects on average only 10% of patients
and generally wanes several days or weeks after the medication has been introduced [37].
Nevertheless, future research should account for the potential influence of ACE inhibitor
use on cough frequency.
To the best of our knowledge, this is the first study to report an association between
hourly cough frequency and the incidence of pneumonia in dysphagic patients after
stroke. We were able to show, that in our study cohort, cough frequency measured with
LEOSound® cough monitors had a similar predictive value for the diagnosis of pneumonia
as PAS according to FEES.
The current coronavirus pandemic has imposed numerous restrictions on clinical
procedures that carry a high risk of virus transmission, such as dysphagia and cough
diagnostics. Instrumental swallowing examinations have only been used for the evaluation
of the severely affected [38], and dysphagia has been evaluated mainly through clinical
assessment. Observer-based assessment of cough has been restricted due to the risk of
exposure to aerosols for both staff and patients [39]. In this current situation, and potentially
in health care systems in which access to instrumental diagnostic equipment is only possible
to a limited extent, systems like LEOSound® could potentially offer a safe alternative to
instrumental diagnostic for the estimation of pneumonia risk, while reducing the potential
for exposure to aerosols and secretions.
There are practical aspects to our research: continuous monitoring of cough frequency
during the night, when the risk of silent aspiration is often higher, may be an effective
and, in contrast to FEES, non-invasive method. If the results obtained in this study can be
validated in future clinical studies, this may lead to enhanced preventive procedures in
stroke and rehabilitation facilities.
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Strengths and Limitations
The strengths of this study were the prospective study design with consecutive re-
cruitment and the long-standing experience of the clinical team in conducting clinical and
instrumental swallowing diagnostics. The analysis was limited due to the small sample
size and the study should be viewed as exploratory.
Despite this limitation, it may be concluded that in our study cohort HCR values
recorded by LEOSound® had similar predictive value for pneumonia outcome as PAS
according to FEES. Based on these findings, it is warranted to conduct further studies to
investigate the following research question: is higher nocturnal cough frequency in patients
with dysphagia after stroke an indicator of the cough defense mechanisms against aspira-
tion and therefore a warning sign for pneumonia? In order to conduct a definitive study,
our data could be used to conduct a prospective sample-size calculation, and eligibility
criteria would have to be carefully considered. In future studies, it would be helpful to in-
clude repeated assessments of cough frequency to examine possible relationships to change
in the swallowing function and to determine the stability of HCR measurements over time.
Additionally, all three relevant aspects of cough—frequency, reflex cough sensitivity, and
peak cough flow—should be investigated as potential predictors of pneumonia, especially
in dysphagic patients who are highly exposed to pneumonia.
5. Conclusions
Increased cough frequency measured with a nocturnal cough monitor was an inde-
pendent predictor of pneumonia in dysphagic stroke patients. Further studies are required
to confirm the clinical utility of cough monitoring in this patient group. As a non-invasive
assessment method with low infection risk, cough monitoring may offer a viable alternative
or complementary method to instrumental diagnostics of swallowing.
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